Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations

被引：8
|
作者：
Claudiani, Simone [1 ,2 ]
Apperley, Jane F. [1 ,2 ]
Khan, Afzal [2 ]
Khorashad, Jamshid [2 ]
Milojkovic, Dragana [1 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London, England
[2] Imperial Coll London, Hammersmith Hosp, Dept Immun & Inflammat, Ctr Haematol,Fac Med, London, England
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 05期
关键词：
MOLECULAR RESPONSE; CLINICAL-PRACTICE; INHIBITORS; IMATINIB; DISCONTINUATION; RECOMMENDATIONS; GUIDELINES; DASATINIB;
D O I：
10.3324/haematol.2019.234179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E225 / E227
页数：3
相关论文
共 50 条
  • [1] Treatment-Free Remission in Chronic Myeloid Leukemia Harboring Atypical BCR-ABL1 Transcripts
    Dragani, Matteo
    Petiti, Jessica
    Rege-Cambrin, Giovanna
    Gottardi, Enrico
    Daraio, Filomena
    Caocci, Giovanni
    Aguzzi, Chiara
    Crisa, Elena
    Andreani, Giacomo
    Caciolli, Francesca
    Fava, Carmen
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [2] Treatment-free remission in e19a2 BCR-ABL1 chronic myeloid leukemia
    Kajiguchi, Tomohiro
    Hashimoto, Ken
    Shimizu, Rie
    Okuno, Shingo
    Takagi, Erina
    ANNALS OF ONCOLOGY, 2021, 32 : S356 - S356
  • [3] Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
    Soverini, Simona
    de Benedittis, Caterina
    Mancini, Manuela
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S120 - S128
  • [4] STUDY OF MUTATIONS IN THE KINASE DOMAIN OF BCR-ABL1 BY NGS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Stuckey, Ruth
    Florido, Ortega Yanira
    Rodriguez, Lopez Juan Francisco
    Bilbao, Sieyro Cristina
    Gomez, Casares Maria Teresa
    HAEMATOLOGICA, 2020, 105 : 239 - 239
  • [5] Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia
    Shanmuganathan, Naranie
    Pagani, Ilaria S.
    Ross, David M.
    Park, Sahee
    Yong, Agnes S. M.
    Braley, Jodi A.
    Altamura, Haley K.
    Hiwase, Devendra K.
    Yeung, David T.
    Kim, Dong-Wook
    Branford, Susan
    Hughes, Timothy P.
    BLOOD, 2021, 137 (09) : 1196 - 1207
  • [6] Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Langabeer, Stephen E.
    McCarron, Sarah L.
    Haslam, Karl
    Preston, Lisa
    CLINICAL LABORATORY, 2016, 62 (05) : 975 - 976
  • [7] BCR-ABL1 Transcript Doubling Time after Imatinib Discontinuation for Treatment-Free Remission in Chronic Myeloid Leukemia in Chronic Phase: Predictor for Treatment-Free Remission Failure
    Kim, Dennis Dong Hwan
    Novitzky-Basso, Igor Nicolas
    Kim, Taehyung
    Atenafu, Eshetu G.
    Forrest, Donna L.
    Savoie, Lynn
    Bence-Bruckler, Isabelle
    Keating, Mary-Margaret
    Busque, Lambert
    Delage, Robert
    Xenocostas, Anargyros
    Liew, Elena
    Paulson, Kristjan
    Stockley, Tracy L.
    Laneuville, Pierre
    Lipton, Jeffrey H.
    Kamel-Reid, Suzanne
    Leber, Brian
    BLOOD, 2020, 136
  • [8] Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib
    Marce, Silvia
    Xicoy, Blanca
    Garcia, Olga
    Cabezon, Marta
    Estrada, Natalia
    Velez, Patricia
    Boque, Concepcion
    Sagues, Miguel
    Angona, Anna
    Teruel-Montoya, Raul
    Ferrer-Marin, Francisca
    Amat, Paula
    Hernandez-Boluda, Juan Carlos
    Ibarra, Mariana M.
    Anguita, Eduardo
    Cortes, Montserrat
    Fernandez-Ruiz, Andres
    Fontanals, Sandra
    Zamora, Lurdes
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [9] Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
    Erbilgin, Yucel
    Eskazan, Ahmet Emre
    Ng, Ozden Hatirnaz
    Salihoglu, Ayse
    Elverdi, Tugrul
    Firtina, Sinem
    Tasar, Orcun
    Mercan, Sevcan
    Sisko, Sinem
    Khodzhaev, Khusan
    Ongoren, Seniz
    Ar, Muhlis Cem
    Baslar, Zafer
    Soysal, Teoman
    Sayitoglu, Muge
    Ozbek, Ugur
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 200 - 207
  • [10] A Novel BCR-ABL1 Degrader, Ubx-362, Can Overcome Resistance By BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Lim, Ye Seul
    Jeong, Na-Rae
    Yoo, Sun-Mi
    Kim, Han Wool
    Lee, Song Hee
    Kim, Dong-Wook
    BLOOD, 2023, 142
12345